Reduced Levels of ATF-2 Predispose Mice to Mammary Tumors

REFERENCES

• Baylin, S., and T. H. Bestor. 2002. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1:299–305.
   PubMed Web of Science ®Google Scholar
• Beier, F., R. J. Lee, A. C. Taylor, R. G. Pestell, and P. LuValle. 1999. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc. Natl. Acad. Sci. USA 96:1433–1438.
   PubMedGoogle Scholar
• Benbrook, D. M., and N. C. Jones. 1990. Heterodimer formation between CREB and JUN proteins. Oncogene 5:295–302.
   PubMed Web of Science ®Google Scholar
• Bhoumik, A., S. Takahashi, W. Breitweiser, Y. Shiloh, N. Jones, and Z. Ronai. 2005. ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol. Cell 18:577–587.
   PubMed Web of Science ®Google Scholar
• Bulavin, D. V., C. Phillips, B. Nannenga, O. Timofeev, L. A. Donehower, C. W. Anderson, E. Appella, and A. J. Fornace, Jr. 2004. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway. Nat. Genet. 36:343–350.
   PubMed Web of Science ®Google Scholar
• Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37–40.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Falvo, J. V., B. S. Parekh, C. H. Lin, E. Fraenkel, and T. Maniatis. 2000. Assembly of a functional beta-interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation. Mol. Cell. Biol. 20:4814–4825.
   PubMedGoogle Scholar
• Fukuda, Y., N. Kurihara, I. Imoto, K. Yasui, M. Yoshida, K. Yanagihara, J. G. Park, Y. Nakamura, and J. Inazawa. 2000. CD44 is a potential target of amplification within the 11p13 amplicon detected in four of 25 gastric cancer cell lines. Genes Chromosome Cancer 29:315–324.
   PubMedGoogle Scholar
• Gaire, M., B. Chatton, and C. Kedinger. 1990. Isolation and characterization of two novel, closely related ATF cDNA clones from HeLa cells. Nucleic Acids Res. 18:3467–3473.
   PubMedGoogle Scholar
• Gupta, S., D. Campbell, B. Dérijard, and R. J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389–393.
   PubMed Web of Science ®Google Scholar
• Hai, T., and T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720–3724.
   PubMed Web of Science ®Google Scholar
• Hai, T. W., F. Liu, E. A. Allegretto, M. Karin, and M. R. Green. 1988. A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev. 2:1216–1226.
   PubMedGoogle Scholar
• Hockel, M., and P. Vaupel. 2001. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93:266–276.
   PubMed Web of Science ®Google Scholar
• Hollander, M. C., M. S. Sheikh, D. V. Bulavin, K. Lundgren, L. Augeri-Henmueller, R. Shehee, T. A. Molinaro, K. E. Kim, E. Tolosa, J. D. Ashwell, M. P. Rosenberg, Q. Zhan, P. M. Fernandez-Salguero, W. F. Morgan, C. X. Deng, and A. J. Fornace, Jr. 1999. Genomic instability in Gadd45α-deficient mice. Nat. Genet. 23:176–184.
   PubMed Web of Science ®Google Scholar
• Huguier, S., J. Baguet, S. Perez, H. van Dam, and M. Castellazzi. 1998. Transcription factor ATF2 cooperates with v-Jun to promote growth factor-independent proliferation in vitro and tumor formation in vivo. Mol. Cell. Biol. 18:7020–7029.
   PubMedGoogle Scholar
• Ivashkiv, L. B., H. C. Liou, C. J. Kara, W. W. Lamph, I. M. Verma, and L. H. Glimcher. 1990. mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Mol. Cell. Biol. 10:1609–1621.
   PubMedGoogle Scholar
• Jin, W., T. Takagi, S. N. Kanesashi, T. Kurahashi, T. Nomura, J. Harada, and S. Ishii. 2006. Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins. Dev. Cell. 10:461–471.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G. 2005. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74:115–128.
   PubMed Web of Science ®Google Scholar
• Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597.
   PubMed Web of Science ®Google Scholar
• Kim, M. S., E. J. Lee, H. R. Kim, and A. Moon. 2003. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63:5454–5461.
   PubMed Web of Science ®Google Scholar
• Knudson A. G., Jr. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68:820–823.
   PubMed Web of Science ®Google Scholar
• Kondo, S., T. Murakami, K. Tatsumi, M. Ogata, S. Kanemoto, K. Otori, K. Iseki, A. Wanaka, and K. Imaizumi. 2005. OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes. Nat. Cell Biol. 7:186–194.
   PubMed Web of Science ®Google Scholar
• Liu, J., S. Yin, N. Reddy, C. Spencer, and S. Sheng. 2004. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res. 64:1703–1711.
   PubMed Web of Science ®Google Scholar
• Livingstone, C., G. Patel, and N. Jones. 1997. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14:1785–1797.
   Google Scholar
• Maekawa, T., F. Bernier, M. Sato, S. Nomura, M. Singh, Y. Inoue, T. Tokunaga, H. Imai, M. Yokoyama, A. Reimold, L. H. Glimcher, and S. Ishii. 1999. Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J. Biol. Chem. 274:17813–17819.
   PubMedGoogle Scholar
• Maekawa, T., H. Sakura, C. Kanei-Ishii, T. Sudo, T. Yoshimura, J. Fujisawa, M. Yoshida, and S. Ishii. 1989. Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J. 8:2023–2028.
   PubMed Web of Science ®Google Scholar
• Matsuda, S., T. Maekawa, and S. Ishii. 1991. Identification of the functional domains of the transcriptional regulator CRE-BP1. J. Biol. Chem. 266:18188–18193.
   PubMedGoogle Scholar
• Mita, H., J. Tsutsui, M. Takekawa, E. A. Witten, and H. Saito. 2002. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol. Cell. Biol. 22:4544–4555.
   PubMed Web of Science ®Google Scholar
• Morooka, H., J. V. Bonventre, C. M. Pombo, J. M. Kyriakis, and T. Force. 1995. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter. J. Biol. Chem. 270:30084–30092.
   PubMedGoogle Scholar
• Morrison, D. K., and R. J. Davis. 2003. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19:91–118.
   PubMed Web of Science ®Google Scholar
• Nagadoi, A., K. Nakazawa, H. Uda, K. Okuno, T. Maekawa, S. Ishii, and Y. Nishimura. 1999. Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain. J. Mol. Biol. 287:593–607.
   PubMedGoogle Scholar
• Neve, R. M., T. Holbro, and N. E. Hynes. 2002. Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells. Oncogene 21:4567–4576.
   PubMed Web of Science ®Google Scholar
• Nomura, N., Y. L. Zu, T. Maekawa, S. Tabata, T. Akiyama, and S. Ishii. 1993. Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1. J. Biol. Chem. 268:4259–4266.
   PubMed Web of Science ®Google Scholar
• Ouwens, D. M., N. D. de Ruiter, G. C. van der Zon, A. P. Carter, J. Schouten, C. van der Burgt, K. Kooistra, J. L. Bos, J. A. Maassen, and H. van Dam. 2002. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 21:3782–3793.
   PubMed Web of Science ®Google Scholar
• Page, D. L., and T. J. Anderson. 1987. Diagnostic histopathology of the breast. Churchill Livingstone, London, United Kingdom.
   Google Scholar
• Persengiev, S. P., and M. R. Green. 2003. The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 8:225–228.
   PubMed Web of Science ®Google Scholar
• Reimold, A. M., M. J. Grusby, B. Kosaras, J. W. Fries, R. Mori, S. Maniwa, I. M. Clauss, T. Collins, R. L. Sidman, M. J. Glimcher, and L. H. Glimcher. 1996. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379:262–265.
   PubMedGoogle Scholar
• Sano, Y., J. Harada, S. Tashiro, R. Gotoh-Mandeville, T. Maekawa, and S. Ishii. 1999. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274:8949–8957.
   PubMed Web of Science ®Google Scholar
• Sano, Y., F. Tokitou, P. Dai, T. Maekawa, T. Yamamoto, and S. Ishii. 1998. CBP alleviates the intramolecular inhibition of ATF-2 function. J. Biol. Chem. 273:29098–29105.
   PubMedGoogle Scholar
• Shimizu, M., Y. Nomura, H. Suzuki, E. Ichikawa, A. Takeuchi, M. Suzuki, T. Nakamura, T. Nakajima, and K. Oda. 1998. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. Exp. Cell Res. 239:93–103.
   PubMedGoogle Scholar
• Shinagawa, T., and S. Ishii. 2003. Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev. 17:1340–1345.
   PubMed Web of Science ®Google Scholar
• Shinagawa, T., T. Nomura, C. Colmenares, M. Ohira, A. Nakagawara, and S. Ishii. 2001. Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 20:8100–8108.
   PubMedGoogle Scholar
• Takeda, J., T. Maekawa, T. Sudo, Y. Seino, H. Imura, N. Saito, C. Tanaka, and S. Ishii. 1991. Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. Oncogene 6:1009–1114.
   PubMedGoogle Scholar
• Takekawa, M., and H. Saito. 1998. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95:521–530.
   PubMed Web of Science ®Google Scholar
• Tamura, K., B. Hua, S. Adachi, I. Guney, J. Kawauchi, M. Morioka, M. Tamamori-Adachi, Y. Tanaka, Y. Nakabeppu, M. Sunamori, J. M. Sedivy, and S. Kitajima. 2005. Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. EMBO J. 24:2590–2601.
   PubMedGoogle Scholar
• van Dam, H., M. Duyndam, R. Rottier, A. Bosch, L. de Vries-Smits, P. Herrlich, A. Zantema, P. Angel, and A. J. van der Eb. 1993. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:479–487.
   PubMed Web of Science ®Google Scholar
• van Dam, H., D. Wilhelm, I. Herr, A. Steffen, P. Herrlich, and P. Angel. 1997. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:31798–31811.
   Google Scholar
• van Dam, H., S. Huguier, K. Kooistra, J. Baguet, E. Vial, A. J. van der Eb, P. Herrlich, P. Angel, and M. Castellazzi. 1998. Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev. 12:1227–1239.
   PubMedGoogle Scholar
• Venkitaraman, A. R. 2002. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182.
   PubMed Web of Science ®Google Scholar
• Yasui, K., I. Imoto, Y. Fukuda, A. Pimkhaokham, Z. Q. Yang, T. Naruto, Y. Shimada, Y. Nakamura, and J. Inazawa. 2001. Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 32:112–118.
   PubMedGoogle Scholar
• Yoshida, H., T. Matsui, A. Yamamoto, T. Okada, and K. Mori. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881–891.
   PubMed Web of Science ®Google Scholar
• Zou, Z., A. Anisowicz, M. J. Hendrix, A. Thor, M. Neveu, S. Sheng, K. Rafidi, E. Seftor, and R. Sager. 1994. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526–529.
   PubMed Web of Science ®Google Scholar